Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Peripheral Nervous System Diseases

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Peripheral Nervous System Diseases in 2 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garry, EM1
Moss, A1
Rosie, R1
Delaney, A1
Mitchell, R1
Fleetwood-Walker, SM1
Christoph, T1
Schiene, K1
Englberger, W1
Parsons, CG1
Chizh, BA1

Other Studies

2 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Peripheral Nervous System Diseases

ArticleYear
Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit.
    Molecular and cellular neurosciences, 2003, Volume: 24, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carrier Proteins; Cell Membrane;

2003
The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
    Neuropharmacology, 2006, Volume: 51, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics, Opioid; Animals; Cold Temperat

2006